• LevinPro HC Stat of the Week, December 5, 2025

    eHealth Activity Hits 3-Year High (Already) Source: LevinPro HC, December 2025 With still a month left in 2025, eHealth M&A activity has hit a 3-year high, with 280 deal announcements, a 13% increase over last year’s volume. Although AI has been a hot topic in healthcare (and just about everywhere), our LevinPro HC data shows that... Read More »
  • INVO Fertility Acquires Family Beginnings 

    INVO Fertility, part of INVO Bioscience, Inc., reported on November 28 that it was expanding its presence with the acquisition of Family Beginnings.  Family Beginnings is a fertility clinic based in Indianapolis, Indiana. According to its website, the practice is run by Dr. James G. Donahue.  Founded in 2009, INVO Fertility healthcare... Read More »
  • Hims & Hers to Acquire YourBio Health

    Leading health and wellness platform Hims & Hers Health, Inc. announced that it has entered into a definitive agreement to acquire YourBio Health, Inc., a Flagship Pioneering portfolio company. YourBio Health is a Boston-based pioneer in capillary whole blood sampling technology. The company invented ‘Touch-Activated Phlebotomy’ for virtually... Read More »
  • BriteLife Recovery Buys New Jersey-Based Summit Behavioral Health

    BriteLife Recovery will be acquiring Summit Behavioral Health, according to a December 2 announcement. The acquisition marks BriteLife Recovery’s first expansion into outpatient programming. Summit Behavioral Health is a community-based intensive outpatient program (IOP) in Princeton Junction, New Jersey. BriteLife Recovery is a provider of... Read More »
  • INVO Fertility Acquires Family Beginnings 

    INVO Fertility, part of INVO Bioscience, Inc., reported on November 28 that it was expanding its presence with the acquisition of Family Beginnings.  Family Beginnings is a fertility clinic based in Indianapolis, Indiana. According to its website, the practice is run by Dr. James G. Donahue.  Founded in 2009, INVO Fertility healthcare... Read More »
Small World: The Week of International Pharma Deals

Small World: The Week of International Pharma Deals

Last week, the list of pharmaceutical deals announced also could have served as a geography lesson. Not only was the volume of deals particularly high, accounting for nearly 28% of the week’s total, but it had a diverse list of countries. Beginning in the United States, New York City-based Royalty Pharma, which focuses entirely on acquiring royalty interests in marketed and late-stage biopharmaceutical products, acquired the royalty interest in Indianapolis-based Eli Lilly’s (NYSE: LLY) Emgality from Arteaus Therapeutics (Cambridge, Massachusetts) for $260 million. Advanz Pharma Corp. (ADVZ.TO), a Canadian pharmaceutical company, bought the global rights to two drugs for $33.3... Read More »